Webinars
60
min. read
February 6, 2020

Neuroscience Investing in Emerging Sectors

MetaCell, world leaders in software for neuroscience, hosted a live webinar to discuss some of the latest strategies and opportunities for investing in neuroscience.

Neuroscience Investing in Emerging Sectors

Sign up to get access to the recording.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Neuroscience Investing in Emerging Sectors

MetaCell, world leaders in software for neuroscience, hosted a live webinar to discuss some of the latest strategies and opportunities for investing in neuroscience.

Priyal Sheth, EVP of Client Relations at MetaCell, chaired a panel to understand possible future directions neuroscience could take in researching, developing, and funding the next generation of treatments for the brain and nervous system.

Webinar panelists:

  • Valerie Photos, Partner at Iaso Ventures
  • Avery Bedows, Neurotech Investor at Loup Ventures
  • Stephen Larson, CEO and co-founder of MetaCell

By watching the webinar you will:

  • Hear different viewpoints on investing in neuroscience, which take into account specific verticals (i.e. drugs, digital health, behavioral health, disease specific, etc)
  • Understand how investors look at neuroscience data management, and the role it can play to take the industry forward
  • Learn how to go from lab to commercialization
  • Discover how to diminish risks
  • Ask about challenges, failures, and successes of investing in neuroscience
Share this post online